Travere Therapeutics Inc. (TVTX)

Profile

https://travere.com

Travere Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for people living with rare kidney, liver, and metabolic diseases. Its current commercial portfolio includes FILSPARI, a treatment for certain kidney disorders, along with legacy rare-disease products such as Thiola, Thiola EC, Cholbam, and Chenodal. The company also supports specialized care through disease-focused programs and physician engagement aimed at addressing conditions with limited treatment options. Travere Therapeutics Inc. serves patients, healthcare providers, and rare-disease communities across its core therapeutic areas, combining approved medicines with ongoing development work in nephrology and metabolic disease. Headquartered in San Diego, California, Travere Therapeutics Inc. plays a notable role in the rare-disease biopharmaceutical market through its focused product set and concentrated clinical expertise.